Zevra Therapeutics, Inc.

US$11.59As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ZVRAHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (15.02%)
Div yield —
ROE 41.93%
Biotechnology
Beta (5Y) 0.99
PE TTM 9.429
TSR TTM 13.85%
Mkt cap US$689.7M
ROIC 90.44%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
27.93%
(95.05%)
Hold 5|0|4|3|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.10
0.11
0.11
0.10
8.52%
15.54%
16.31%
4.62%
Revenue$M
32.70
33.38
34.80
36.07
6.10%
4.72%
7.95%
12.55%
Peers (US$689.7M)
Cap (US$)
PE
681.7M
26.80x
Capital
TTM
5Y
10Y
Leveragex
1.245
(0.412)
(0.302)
EBIT/Intx
0.931
0.194
0.227
Own earn%
(91.04)
21.05
21.80
Sh yield%
17.78
15.74
15.06
Owners
Insiders/Inst%
12.14
71.39
Short interest%
3.01
SBC / revenue%
5.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
3–8
$1 testx
0.2
Incr. ROIC%
6